arrow
R

Robert Olson

University of British Columbia
H指数:77
被引数:2.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Five-year follow-up of the SABR-5 trial: primary toxicity analysis of stereotactic ablative radiotherapy for up to five oligometastases

SABR-5试验的五年随访:针对最多五个寡转移灶的立体定向消融放射治疗的主要毒性分析

2026-05-150
OAAI
Multinational Validation of Distant Metastasis Velocity as a Post-Progression Prognostic Score in Patients with Oligometastatic Cancer Treated with Metastasis-Directed Stereotactic Body Radiotherapy

多国验证远处转移速度作为接受转移灶定向立体定向体部放疗的寡转移癌患者中的一种疾病进展后预后评分

2025-08-230
OAAI
Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial
2025-01-012
PRE
Predictors of Quality of Life Decline in Patients with Oligometastases treated with Stereotactic Ablative Radiotherapy: Analysis of the-Based SABR-5 Phase II Trial
2024-03-012
PRE
Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET
2024-02-030
OAAI
Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trial
2023-05-0112
PRE
Determining Planning Priorities for SABR for Oligometastatic Disease: A Secondary Analysis of the SABR-COMET Phase II Randomized Trial
2022-12-0117
PRE
Progression-Free Survival and Local Control After SABR for up to 5 Oligometastases: An Analysis From the Population-Based Phase 2 SABR-5 Trial
2022-11-0127
PRE